Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP
- PMID: 12874452
- DOI: 10.1097/01.asn.0000078960.15147.05
Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP
Abstract
Angiotensin-converting enzyme inhibitors and aldosterone receptor antagonists ameliorate malignant nephrosclerotic lesions of thrombotic microangiopathy in salt-loaded, stroke-prone, spontaneously hypertensive rats (SHRSP) without controlling hypertension. This suggests that angiotensin II (Ang II) and/or aldosterone (ALDO) plays a critical role in renal injury in this model. For evaluating their relative roles in the pathogenesis of thrombotic microangiopathy, SHRSP were adrenalectomized and infused with vehicle, Ang II, or ALDO or were sham-operated for adrenalectomy (SHAM). Saline-drinking rats were assigned to one of four groups: SHAM, adrenalectomy, adrenalectomy + Ang II (25 ng/min, subcutaneously), or adrenalectomy + ALDO (40 micro g/kg per d, subcutaneously). All SHRSP received dexamethasone (12 micro g/kg per d, subcutaneously). Adrenalectomy did not show changes in body weight, plasma creatinine, sodium and potassium, and daily urinary sodium and potassium excretion; did not prevent hypertension but prevented proteinuria (12 +/- 1 versus 49 +/- 3 mg/d; P < 0.01); and abrogated thrombotic microangiopathy and decreased plasma aldosterone (<16 versus 710 +/- 91 pg/ml; P < 0.001) compared with SHAM. Systolic BP in adrenalectomy + Ang II and adrenalectomy + ALDO (238 +/- 8 and 241 +/- 9 mmHg, respectively) was similar to SHAM. Despite Ang II infusion, proteinuria (17 +/- 9 mg/d) and thrombotic microangiopathy and plasma aldosterone (18 +/- 18 pg/ml) remained low but daily urinary excretion of sodium and potassium were not different from adrenalectomy + ALDO. Adrenalectomy + ALDO showed plasma aldosterone levels of 735 +/- 147 pg/ml; plasma potassium was lower; plasma creatinine and proteinuria (78 +/- 7 mg/d) were greater and thrombotic microangiopathy lesions were comparable to SHAM. These results demonstrate a pivotal role for aldosterone in the development of thrombotic microangiopathy, independent of hypertension.
Similar articles
-
Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.Endocrinology. 2002 Dec;143(12):4828-36. doi: 10.1210/en.2002-220120. Endocrinology. 2002. PMID: 12446610
-
Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats.Hypertension. 1999 Jan;33(1 Pt 2):232-7. doi: 10.1161/01.hyp.33.1.232. Hypertension. 1999. PMID: 9931110
-
Sodium transport antagonism reduces thrombotic microangiopathy in stroke-prone spontaneously hypertensive rats.Am J Physiol Renal Physiol. 2004 Jun;286(6):F1185-92. doi: 10.1152/ajprenal.00355.2003. Epub 2004 Feb 24. Am J Physiol Renal Physiol. 2004. PMID: 14982815
-
Role of cardiovascular aldosterone in hypertension.Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):261-6. doi: 10.2174/1568016054368151. Curr Med Chem Cardiovasc Hematol Agents. 2005. PMID: 15974890 Review.
-
Pathophysiological effects of aldosterone in cardiovascular tissues.Trends Endocrinol Metab. 2001 Sep;12(7):308-14. doi: 10.1016/s1043-2760(01)00432-5. Trends Endocrinol Metab. 2001. PMID: 11504670 Review.
Cited by
-
Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study.BMC Nephrol. 2023 Mar 22;24(1):68. doi: 10.1186/s12882-023-03117-1. BMC Nephrol. 2023. PMID: 36949416 Free PMC article.
-
New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?Exp Biol Med (Maywood). 2016 Nov;241(17):1888-1899. doi: 10.1177/1535370216660211. Epub 2016 Jul 19. Exp Biol Med (Maywood). 2016. PMID: 27439538 Free PMC article. Review.
-
Role of aldosterone in various target organ damage in patients with hypertensive emergency: a cross-sectional study.BMC Nephrol. 2024 Oct 10;25(1):342. doi: 10.1186/s12882-024-03769-7. BMC Nephrol. 2024. PMID: 39390382 Free PMC article.
-
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology.Oxid Med Cell Longev. 2018 Sep 19;2018:1204598. doi: 10.1155/2018/1204598. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30327709 Free PMC article. Review.
-
Enhanced Thrombotic Responses Are Associated With Striatin Deficiency and Aldosterone.J Am Heart Assoc. 2021 Nov 16;10(22):e022975. doi: 10.1161/JAHA.121.022975. Epub 2021 Nov 3. J Am Heart Assoc. 2021. PMID: 34729990 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous